News - Gilead Sciences, daclatasvir


Popular Filters

New drug combo cures toughest cases of hepatitis C, hints to future injection-free therapies


Efforts to cure hepatitis C, the liver-damaging infectious disease that has for years killed more Americans…

Anti-viralsBristol-Myers SquibbdaclatasvirGilead SciencesPharmaceuticalResearchsofosbuvir

Highlights of presentations from Bristol-Myers, J&J, Gilead and AbbVie at EASL meeting


Among a number of drug and biotech majors planning to present at the 2013 annual meeting of the European…

AbbVieAnti-viralsasunaprevirBiotechnologyBristol-Myers SquibbdaclatasvirGilead SciencesJohnson & JohnsonPharmaceuticalResearchsimeprevirsofosbuvir

Back to top